(RTTNews) - Humacyte, Inc. (HUMA), a biotechnology company, Tuesday announced its plan to file an Investigational New Drug or IND application with the U.S. FDA in 2025 to support a first-in-human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback